Use of Diltiazem in Chronic Rate Control for Atrial Fibrillation: A Prospective Case-Control Study

SIMPLE SUMMARY: Recent ESC Atrial Fibrillation guidelines introduced some changes in the options for rate control, such as the possibility to combine beta-blockers and non-dihydropyridine calcium channel blockers to address the need for a personalised pharmacologic rate control treatment for AF. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Diemberger, Igor, Spadotto, Alberto, Massaro, Giulia, Amadori, Martina, Damaschin, Liviu, Martignani, Cristian, Ziacchi, Matteo, Biffi, Mauro, Galiè, Nazzareno, Boriani, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855170/
https://www.ncbi.nlm.nih.gov/pubmed/36671715
http://dx.doi.org/10.3390/biology12010022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855170/
https://www.ncbi.nlm.nih.gov/pubmed/36671715
http://dx.doi.org/10.3390/biology12010022

Ejemplares similares